95253 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
Nuclear Transport Modulators And Uses Thereof
#2702Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases
#2703FUSED CYCLOALKYL-PYRIMIDINE COMPOUNDS AND USES THEREOF
#2704Compounds for the treatment of HIV
#2705Methods for treating MS using pyrimidine and pyridine compounds with BTK inhibitory activity
#2706Cyclic amine azaheterocyclic carboxamides
#2707Tetrazolones as a carboxylic acid bioisosteres
#2708Organic electroluminescent materials and devices
#2709Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
#2710Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2)
#2711Compounds
#2712Inhibitors of RET
#2713Auristatin derivatives and conjugates thereof
#27142-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated to osteoarthritis
#2715ELECTRON BUFFERING MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#2716TrkA kinase inhibitors, compositions and methods thereof
#2717Histone demethylase inhibitors
#2718Benzimidazole derivatives
#2719PYRIDAZINONE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS AND METHODS OF TREATING DISORDERS
#2720Deuterated compounds for treating hematologic malignancies, and compositions and methods thereof
#2721Inhibitors of lysine specific demethylase-1
#2722Treatment of GVHD
#2723Monomers and oligonucleotides comprising cycloaddition adduct(s)
#2724TrkA kinase inhibitors, compositions and methods thereof
#2725INDOLIN-2-ONE OR PYRROLO-PYRIDIN-2-ONE DERIVATIVES
#2726Quinoxaline derivatives useful as FGFR kinase modulators
#2727Heterocyclic compound and organic light-emitting device comprising same
#2728Sepiapterin reductase inhibitors
#2729Macrocycles with aromatic P2′ groups as factor xia inhibitors
#2730Carboxamide derivatives and use thereof
#2731Organic light-emitting device
#2732Controlled crosslinking of latex polymers with polyfunctional amines
#2733Substituted indol-5-ol derivatives and their therapeutical applications
#2734Compounds and methods for inhibiting JAK
#27351 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor
#2736Formulations of luminescent compounds
#2737Stimulus-responsive supramolecular glasses
#2738Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
#27392,4-pyrimidinediamine compounds and their uses
#2740AN ELECTRON TRANSPORT MATERIAL AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME
#2741Substituted heteroaryl compounds and methods of use
#2742Pyrazolyl-substituted heteroaryls and their use as medicaments
#2743Treatments for gastrointestinal conditions
#2744Multivalent ligands targeting VEGFR
#2745Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
#27462-pyrazine carboxamides as spleen tyrosine kinase inhibitors
#2747Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
#2748Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
#2749Organic photoelectric device and image sensor
#2750Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
#2751Substituted pyrimidine compounds
#2752Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methods
#2753NEW PHENYLAZETIDINECARBOXYLATE OR -CARBOXAMIDE COMPOUNDS
#2754Amido compounds as RORγt modulators and uses thereof
#2755Method of treating psoriatic arthritis, psoriasis, and chronic obstructive pulmonary disease with a novel 2,5-substituted pyrimidines
#2756Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
#2757Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device
#2758Organic electroluminescent element and electronic device
#2759Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives
#2760Compositions useful for treating disorders related to kit
#2761Amide compounds for treatment of medical disorders
#2762Marinopyrrole derivatives and methods of making and using same
#2763Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#2764HETEROARYL-SUBSTITUTED 1,3-DIHYDROINDOL-2-ONE DERIVATIVES AND MEDICAMENTS CONTAINING THEM
#2765Triaminopyrimidine compounds useful for preventing or treating malaria
#2766Uracil derivatives as AXL and c-MET kinase inhibitors
#2767Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#2768Electron transport material and organic electroluminescent device comprising the same
#2769Light-emitting material, organic light-emitting device, and compound
#2770Azetidine-substituted fluorescent compounds
#2771PROCESS FOR SCAVENGING HYDROGEN SULFIDE PRESENT IN A FLUID STREAM
#2772Fused bicyclic 1,2,4-triazine compounds as TAM inhibitors
#2773Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
#2774Disubstituted 1, 2, 4-triazine compound
#2775Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
#2776Diphenylimidazole-fused, spirally configured cis-stilbene/fluorene hybrid compounds and organic light emitting device comprising the same
#2777Spirally configured cis-stilbene/fluorene hybrid compounds and organic light emitting device comprising the same
#2778Compound and organic electronic device using the same
#2779BCR-ABL diploid inhibitor, synthesizing method therefor, and uses thereof
#2780Oxopiperazine helix mimetics as inhibitors of the p53-MDM2 interaction
#2781Materials for organic electroluminescent devices
#2782Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
#2783Compositions useful for treating disorders related to kit
#2784Antiviral compounds
#2785Potent and selective inhibitors of hepatitis C virus
#2786Binding function (BF) site compounds as therapeutics and methods for their use
#2787Heterocyclic compounds and uses thereof
#2788Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
#2789Benzamides
#2790Benzimidazole derivatives and preparation process and pharmaceutical uses thereof
#2791Materials for organic electroluminescent devices
#2792Spiro compound having azafluorene ring structure, light-emitting material, and organic electroluminescent device
#2793COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE
#2794Pyrrole compounds as Granzyme B inhibitors
#2795Pyrimidine derivatives
#2796Heteroaromatic derivatives and their use as pharmaceuticals
#2797PYRIDAZINE COMPOUND
#2798Substituted 2-azabicycles and their use as orexin receptor modulators
#2799Pyrimidone carboxamide compounds as PDE2 inhibitors
#2800PKM2 modulators and methods for their use
#2801HETEROARYL SYK INHIBITORS
#2802Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
#2803Heterocyclic amides as kinase inhibitors
#2804Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#2805ELECTRON BUFFERING MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE
#2806Azaspiro derivatives as TRPM8 antagonists
#2807Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
#2808GLS1 inhibitors for treating disease
#2809Indazoles and use thereof
#2810Use of benzimidazole-proline derivatives
#2811Imidazotriazine derivatives as modulators of TNF activity
#2812Syk inhibitors
#2813Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
#2814Plant growth regulating compounds
#2815DNA-PK inhibitors for treatment of cancer
#2816OLEFIN SUBSTITUTED OXINDOLES HAVING AMPK ACTIVITY
#2817ETHER COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#2818Fused heterocyclic compounds as ion channel modulators
#2819Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
#2820Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
#2821Avanafil preparation method
#2822ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#2823Amide compounds for treatment of complement mediated disorders
#2824COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#2825Pharmaceutical compounds
#2826MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES
#2827Dimeric IAP inhibitors
#2828Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
#2829Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
#2830Heteroaryl inhibitors of sumo activating enzyme
#2831Triazoles for the treatment of Demyelinating Diseases
#2832Articles and methods comprising persistent carbenes and related compositions
#2833Organic compound, composition, organic optoelectronic diode, and display device
#2834Benzamide and nicotinamide compounds and methods of using same
#2835Pyrrole-substituted indolone derivative, preparation method therefor, composition comprising same and use thereof
#2836Processes and intermediates for making a JAK inhibitor
#2837Triazine based radiopharmaceuticals and radioimaging agents
#2838Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
#2839Synthesis of antiviral compound
#2840BENZIMIDAZOLE-IMIDAZOLE DERIVATIVES
#2841Kinase inhibitors
#2842Substituted benzooxadiazole DNA-PK inhibitors
#2843Hepatitis C virus inhibitors
#2844Heterocyclic modulators of lipid synthesis and combinations thereof
#2845Pyrazolyl pyrimidinamine compound and application thereof
#2846Heterocyclic compounds useful as PDK1 inhibitors
#2847COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, INK COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#2848Infrared-sensitive color developing composition, lithographic printing plate precursor, plate making method for lithographic printing plate, and infrared-sensitive color developer
#2849Heteroaryl substituted pyrazoles
#2850PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
#2851Pyrazolyl-heteroarylamides as pesticides
#2852Condensed fluoranthene compound, material for organic electroluminescent element using this compound, organic electroluminescent element using this material, and electronic device
#2853Compound and organic light-emitting device comprising the same
#2854High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixture-based libraries
#2855Diazepane orexin receptor antagonists
#2856Substituted aminopyrimidine compounds and methods of use
#2857Imidazolidine-2,4-dione dervatives
#2858Inhibitors of bruton's tyrosine kinase
#28594-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors
#2860HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE
#2861Allosteric modulators of factor XIa as anticoagulant agents
#2862SGC STIMULATORS
#2863Compositions and methods for inhibiting kinases
#2864Heterocyclic compound
#2865Heterocyclic modulators of lipid synthesis
#2866Inhibitors of bruton's tyrosine kinase
#2867Pyrazolyl quinoxaline kinase inhibitors
#2868Hepatitis C virus inhibitors
#2869Substituted indazole derivatives active as kinase inhibitiors
#2870Compounds as TNIK, IKKε and TBK1 inhibitors and pharmaceutical composition comprising same
#2871Alkylating agent for alkylating target with driver oncogene mutation
#2872Pyridinyl and fused pyridinyl triazolone derivatives
#2873Substituted indazole derivatives active as kinase inhibitiors
#2874Light-emitting material, and delayed fluorescent emitter and organic light-emitting device using same
#2875Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device
#2876Inhibitors of lysine specific demethylase-1
#2877Methods of promoting wound healing using CRM1 inhibitors
#2878LXR modulators
#2879INDAZOLONES AS MODULATORS OF TNF SIGNALING
#2880NOVEL COMPOUNDS AS JNK KINASE INHIBITORS
#2881Serine/threonine kinase inhibitors
#2882Diazole lactams
#28839,9,10,10-Tetrafluoro-9,10-dihydrophenanthrene hepatitis C virus inhibitor and application thereof
#2884Fluoromethyl-substituted pyrrole carboxamides iv
#2885Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics
#2886Aryl-substituted imidazoles
#2887Substituted triazine BMI-1 inhibitors
#2888Piperidine or piperazine linked imidazole and triazole derivatives and methods of use
#2889Substituted quinazoline compounds and methods of use thereof
#2890NOVEL IMIDAZOLE DERIVATIVES AND THERAPEUTIC USE THEREOF
#2891Organic electroluminescent material, organic electroluminescent device and quantum dot electroluminescent unit
#2892Bipyrazole derivatives as JAK inhibitors
#2893Fluoromethyl-substituted pyrrole carboxamides as CaV2.2 calcium channel blockers
#2894Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases
#2895Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
#2896Substituted pyridine and pyrazine BMI-1 inhibitors
#2897N-pyrrolidinyl,N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#2898Heterocyclic compound and organic light emitting device using the same
#2899Respiratory syncytial virus inhibitors
#2900Compounds and methods for the enhanced degradation of targeted proteins
#2901Tetrazolinone compound and use thereof
#2902Quinazolinone and isoquinolinone derivative
#2903Biscarbazole derivative and organic electroluminescent element using same
#2904Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative
#2905Electronic device including a fluoranthene derivative
#2906Imidazole derivatives
#2907Substituted sulfonamide compounds
#2908Pyrazol-3-ones that activate pro-apoptotic BAX
#2909HETEROMAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLFERATIVE DISEASES
#2910Nonpolar phase-soluble metathesis catalysts
#2911ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
#2912Specific targeting of RNA expanded repeat sequences
#2913Substituted azines as pesticides
#2914Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
#2915Alkylene derivatives
#2916N-cycloalkyl-N-(biheterocyclymethylene)-(thio)carboxamide derivatives
#2917Organic light emitting compound and organic light emitting device comprising the same
#2918Materials for electronic devices
#2919ALIPHATIC-AROMATIC HETEROCYCLIC COMPOUNDS AND USES THEREOF IN METAL EXTRACTANT COMPOSITIONS
#2920Sulfonamide derivative and pharmaceutical use thereof
#2921Heteroaryl Syk inhibitors
#2922EXPANDED THERAPEUTIC POTENTIAL IN NITROHETEROARYL ANTIMICROBIALS
#2923P2X4 receptor antagonist
#2924Substituted uracils as chymase inhibitors
#2925Pyridazinone and pyridone compounds
#2926Substituted triazoles useful as Axl inhibitors
#2927Biscarbazole derivatives and organic electroluminescence device employing the same
#2928Rho kinase inhibitors
#2929SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGICAL DISEASES
#2930Cyanotriazole compounds
#2931Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancer
#2932BIOCOMPATIBLE CROSSLINKED HYDROGELS, DRUG-LOADED HYDROGELS AND METHODS OF USING THE SAME
#2933Arylamide compounds and compositions and uses thereof
#2934Compound, organic electroluminescent element material using same, organic electroluminescent element using this material, and electronic device
#2935Hepatitis C virus inhibitors
#2936Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors
#2937Phtalazinone derivatives and manufacturing process thereof
#2938DENDRITIC COMPOUNDS INCLUDING A CHELATING, FLUOROCHROME OR RECOGNITION AGENT, COMPOSITIONS INCLUDING SAME AND USES THEREOF
#2939SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS
#2940GLP-1 receptor modulators
#2941Benzimidazole derivatives as EP4 antagonists
#2942Oligooxopiperazines and methods of making and using them
#2943Metalloenzyme inhibitor compounds
#2944Autotaxin inhibitor compounds
#2945ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#2946PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF
#2947Liquid crystal composition containing nitrogen-containing cyclic compound and liquid crystal display device
#2948Polyfunctional amines with hydrophobic modification for controlled crosslinking of latex polymers
#2949NOVEL 2,6-DIAMINOPYRIMIDINE DERIVATIVE
#2950Substituted pyrimidine compounds, compositions and medicinal applications thereof
#2951Dihydropyrimidine compounds and their application in pharmaceuticals
#2952Anti-depression compounds
#2953Carbazole derivative, material for organic electroluminescent element which comprises same, and organic electroluminescent element and electronic device each manufactured using same
#2954Heterocyclic compound and organic light-emitting device comprising same
#2955Alkynyl alcohols and methods of use
#2956Indole compound as inhibitor of necrosis
#2957Imidazole-1-yl pyrimidine derivatives, or pharmacutically acceptable salt thereof, and pharmaceutic composition comprising the same as an active ingredient
#2958Compound, organic electroluminescence element material, ink composition, organic electroluminescence element, electronic device, and method for producing compound
#2959Organic electroluminescent element
#2960Indole amide compound as inhibitor of necrosis
#2961Styryl quinazoline derivatives as pharmaceutically active agents
#2962Light-Emitting Element, Organic Compound, Light-Emitting Device, Electronic Device, and Lighting Device
#2963Organic electroluminescence composition, material for organic electroluminescence element, solution of material for organic electroluminescence element, and organic electroluminescence element
#2964Organic material and organic electroluminescent device using the same
#2965Organic material and organic electroluminescent device using the same
#2966Transcriptome-wide design of selective, bioactive small molecules targeting RNA
#2967ALKYNYL ALCOHOLS AND METHODS OF USE
#2968METHOD FOR PRODUCING TRIS-AZIRIDINOMETHANE
#2969Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
#2970METHOD FOR SEPARATION OF A MOLECULAR SPECIES BY SUBLIMATION
#2971Autotaxin inhibitors
#2972Heterocyclyl pyrimidine analogues as TYK2 inhibitors
#2973Substituted bicyclic compounds as bromodomain inhibitors
#2974Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device
#2975Materials for electronic devices
#2976Aromatic amine compound, organic electroluminescent element and electronic device
#2977Azetidine and piperidine compounds useful as PDE10 inhibitors
#29783,5-diaminopyrazole kinase inhibitors
#2979Axl inhibitors
#2980N-cyanomethylamides as inhibitors of janus kinase
#2981Compound and organic electroluminescent element produced using same
#2982Substituted quinazolin-4-one derivatives
#2983HETEROARYL SUBSTITUTED PYRAZOLES
#2984CHEMICAL COMPOUNDS
#2985Inhibitors of plasma kallikrein
#2986Triazine derivative
#2987Compounds
#2988Combinations comprising biphenyl derivatives for use in the treatment of HCV
#2989Chemical compounds
#2990NOVEL UREIDO DERIVATIVES OF NAPHTHALENESULFONIC ACIDS
#2991HETEROARYL COMPOUNDS AND USES THEREOF
#2992Chemical compounds
#2993Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
#2994Chemical compounds
#2995PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#2996Inhibitors of lysine specific demethylase-1
#2997HETEROARYL SUBSTITUTED PYRAZOLES
#2998Non-nucleoside reverse transcriptase inhibitors
#2999Heteroaryl compounds as IRAK inhibitors and uses thereof
#3000Substituted bicyclic compounds as bromodomain inhibitors